- Home
- BTOG vs ALBT Comparison
BTOG vs ALBT Comparison
Compare BTOG & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTOG | ALBT |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 5.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTOG | ALBT |
|---|---|---|
| Price | $4.24 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 102.9K | ★ 123.7K |
| Earning Date | 03-31-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $39,495.00 | ★ $1,611,940.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $0.75 |
| 52 Week High | $60.60 | $11.66 |
Technical Indicators
Market Signals| Indicator | BTOG | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 77.40 | 26.94 |
| Support Level | $3.65 | $0.75 |
| Resistance Level | $5.96 | $1.19 |
| Average True Range (ATR) | 0.55 | 0.10 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 69.89 | 2.15 |
Price Performance
Historical ComparisonAbout BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.